Mindy lee

Mindy Lee, MD, PhD, Instructor, Department of Pediatrics, Division of Endocrinology, Stanford University School of Medicine

Research Description: Dr. Mindy Lee is a pediatric endocrinologist and physician scientist at Stanford University and a K12 DiabDocs program scholar focused on improving pediatric diabetes outcomes by bridging the translation gap between technology development and implementation in clinical practice. Dr. Lee is a physician with experience in clinical research, quality improvement, and diabetes technology. She is further developing her skills in implementation research.

She is a physician lead on a multidisciplinary team to develop and implement inpatient diabetes technology policies at Stanford Health Care and Stanford Medicine Children’s Health. Additionally, she is an investigator on the Teamwork, Targets, and Technology for Tight Glycemia (4T) Study, which is a pragmatic clinical trial to improve glycemia in newly diagnosed youth with T1D through supporting early diabetes technology initiation and remote patient monitoring. She has further applied the 4T remote monitoring program to support use of CGMs for youth with type 1 diabetes and on public insurance with challenges meeting glycemic targets. 

She currently receives support from the Stanford Maternal & Child Health Research Institute (MCHRI) Instructor K Support Award and the Stanford Diabetes Research Center Pilot and Feasibility (SDRC P&F) Award.

Selected relevant publications (Stanford DRC members are in BOLD):

  1. Lee, MY, Ritter, V, Shaw, B, Ferstad, JO, Johari, R, Scheinker, D, Bishop, F, Desai, M, Maahs, DM, & Prahalad, P. (2024). Addressing Disparities Using Continuous Glucose Monitors and Remote Patient Monitoring for Youth With Type 1 Diabetes. Journal of Diabetes Science and Technology, 19322968241305612. https://doi.org/10.1177/19322968241305612 

  2. Lee, MY, Seav, SM, Ongwela, L, Lee, JJ, Aubyrn, R, Cao, FY, Kalinsky, A, Ramos, OA, Gu, Y, Kingston, K, Ivanovic, M, Buckingham, BA, Desai, D, Lal, RA, Tan, M, Basina, M, & Hughes, MS. (2024). Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin. Diabetes Care, 47(10), 1838–1845. https://doi.org/10.2337/dc24-0626. PMID: 39140891; PMCID: PMC11417271. 

  3. Lee, MY, Pham, TD, Maahs, DM, & Prahalad, P. (2024). Recall of High Bias Point-of-Care Hemoglobin A1c Test. Journal of Diabetes Science and Technology, 18(6), 1514–1516. https://doi.org/10.1177/19322968241278744 

  4. Lee, MY, Tanenbaum, ML, Maahs, DM, & Prahalad, P. (2022). Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action. Case Reports in Endocrinology, 2022, 9911736. https://doi.org/10.1155/2022/9911736. PMID: 35273814; PMCID: PMC8904094. 

  5. Hughes MS, Morgan M, Liu YT, Lee MY, Hanes SJ, Hood KK, Buckingham BA, Lal R. Diabetes technology use in U.S. hospitals: A survey of user experiences. Diabetes Obes Metab. 2025 Oct;27(10):6055-6058. doi: 10.1111/dom.16634. Epub 2025 Jul 22. PMID: 40693367; PMCID: PMC12350052. 

  6. Ferstad JO, Vallon JJ, Jun D, Gu A, Vitko A, Morales DP, Leverenz J, Lee MY, Leverenz B, Vasilakis C, Osmanlliu E, Prahalad P, Maahs DM, Johari R, Scheinker D. Population-level management of type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: Precision health meets population health. Pediatr Diabetes. 2021 Nov;22(7):982-991. doi: 10.1111/pedi.13256. Epub 2021 Sep 1. PMID: 34374183; PMCID: PMC8635792. 

  7. Scheinker D, Gu A, Grossman J, Ward A, Ayerdi O, Miller D, Leverenz J, Hood K, Lee MY, Maahs DM, Prahalad P. Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice. JMIR Diabetes. 2022 Jun 6;7(2):e27284. PMID: 35666570; PMCID: PMC9210201. 

  8. Prahalad P, Scheinker D, Desai M, Ding VY, Bishop FK, Lee MY, Ferstad J, Zaharieva DP, Addala A, Johari R, Hood K, Maahs DM. Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes. Nat Med. 2024 Jul;30(7):2067-2075. doi: 10.1038/s41591-024-02975-y. Epub 2024 May 3. PMID: 38702523; PMCID: PMC11847559.